RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
37 hedge funds and large institutions have $9.54M invested in Regulus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
40% less capital invested
Capital invested by funds: $15.9M → $9.54M (-$6.32M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
37
Holding in Top 10
–
Calls
$70K
Puts
$1K
Top Buyers
| 1 | +$1.75M | |
| 2 | +$419K | |
| 3 | +$46K | |
| 4 |
Two Sigma Advisers
New York
|
+$44.2K |
| 5 |
Two Sigma Investments
New York
|
+$17K |
Top Sellers
| 1 | -$2.45M | |
| 2 | -$271K | |
| 3 | -$186K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$170K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$113K |